AMRUTANJAN Stock Overview
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Amrutanjan Health Care Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹689.50 |
| 52 Week High | ₹775.45 |
| 52 Week Low | ₹563.90 |
| Beta | 0.71 |
| 1 Month Change | 12.83% |
| 3 Month Change | 17.47% |
| 1 Year Change | 14.44% |
| 3 Year Change | 9.36% |
| 5 Year Change | 133.37% |
| Change since IPO | 1,392.10% |
Recent News & Updates
Recent updates
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00
Feb 12
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60
Sep 02Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 19Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60
Aug 05Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00
Feb 17Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00
Nov 08Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60
Aug 18Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 30Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?
Apr 08Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years
Mar 11Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares
Feb 24Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?
Feb 14Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 12Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?
Jan 30
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?
Jan 17Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock
Jan 04What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?
Dec 22How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?
Dec 09If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today
Nov 26Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend
Nov 14Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio
Oct 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?
Oct 10I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease
Sep 22What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?
Sep 01With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For
Aug 11Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?
Jul 29Shareholder Returns
| AMRUTANJAN | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 7.2% | -0.1% | 1.8% |
| 1Y | 14.4% | 55.9% | 46.4% |
Return vs Industry: AMRUTANJAN underperformed the Indian Pharmaceuticals industry which returned 55.9% over the past year.
Return vs Market: AMRUTANJAN underperformed the Indian Market which returned 46.4% over the past year.
Price Volatility
| AMRUTANJAN volatility | |
|---|---|
| AMRUTANJAN Average Weekly Movement | 4.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: AMRUTANJAN has not had significant price volatility in the past 3 months.
Volatility Over Time: AMRUTANJAN's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1893 | 537 | Sambhu Sivalenka | www.amrutanjan.com |
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons, stick-on patch, body pain gels, and joint muscle sprays.
Amrutanjan Health Care Limited Fundamentals Summary
| AMRUTANJAN fundamental statistics | |
|---|---|
| Market cap | ₹19.94b |
| Earnings (TTM) | ₹440.09m |
| Revenue (TTM) | ₹3.95b |
45.3x
P/E Ratio5.1x
P/S RatioIs AMRUTANJAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMRUTANJAN income statement (TTM) | |
|---|---|
| Revenue | ₹3.95b |
| Cost of Revenue | ₹2.05b |
| Gross Profit | ₹1.90b |
| Other Expenses | ₹1.46b |
| Earnings | ₹440.09m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 15.22 |
| Gross Margin | 48.15% |
| Net Profit Margin | 11.15% |
| Debt/Equity Ratio | 0.3% |
How did AMRUTANJAN perform over the long term?
See historical performance and comparison